Jin Jun, Dong Yang, Huang Yu, Wu Lili, Yu Lei, Sun Yuanyuan, Zhou Qingshan, Yin Hai-Yan, Gu Wan-Jie
Department of Intensive Care Unit, The First Affiliated Hospital of Jinan University, 613 Huangpu Avenue West, Guangzhou, 510630, China.
Department of Intensive Care Unit, The University of Hong Kong-Shenzhen Hospital, Haiyuan 1St Road, Futian District, Shenzhen, 518000, China.
Mol Neurobiol. 2025 May 6. doi: 10.1007/s12035-025-05005-1.
Sepsis-associated brain dysfunction (SABD) is a critical neurological complication with high mortality, yet its pathogenesis remains poorly understood. This study investigated the role of estrogen-related receptor α (ERRα) in SABD pathogenesis using ERRα knockout (KO) mice and cecal ligation and puncture (CLP) models. We found that ERRα KO mice exhibited improved survival rates, milder neurological symptoms, reduced pro-inflammatory cytokine production (TNF-α, IL-1β), and increased anti-inflammatory cytokine (IL-10) levels compared to wild-type controls. Additionally, ERRα deficiency promoted microglial M2 polarization and attenuated ferroptosis, as evidenced by decreased iron accumulation, reduced lipid peroxidation, and normalized mitochondrial morphology. Mechanistically, these protective effects were mediated through inhibition of the NF-κB signaling pathway. In vitro studies with ERRα knockdown in LPS-stimulated BV2 microglia confirmed these findings. Our results suggest that ERRα as a critical regulator of microglial function in SABD through coordinated control of inflammatory responses, polarization states, and ferroptosis, suggesting that targeting ERRα may represent a promising therapeutic strategy for SABD treatment.
脓毒症相关脑功能障碍(SABD)是一种死亡率高的严重神经并发症,但其发病机制仍知之甚少。本研究使用ERRα基因敲除(KO)小鼠和盲肠结扎穿刺(CLP)模型,研究雌激素相关受体α(ERRα)在SABD发病机制中的作用。我们发现,与野生型对照相比,ERRα KO小鼠的存活率提高,神经症状较轻,促炎细胞因子产生减少(TNF-α、IL-1β),抗炎细胞因子(IL-10)水平升高。此外,ERRα缺乏促进小胶质细胞M2极化并减轻铁死亡,这表现为铁积累减少、脂质过氧化降低和线粒体形态正常化。从机制上讲,这些保护作用是通过抑制NF-κB信号通路介导的。在LPS刺激的BV2小胶质细胞中敲低ERRα的体外研究证实了这些发现。我们的结果表明,ERRα通过协调控制炎症反应、极化状态和铁死亡,作为SABD中关键的小胶质细胞功能调节因子,这表明靶向ERRα可能是一种有前景的SABD治疗策略。